# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T23:39:59.756377
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 17482 in / 6097 out
**Response SHA256:** 8985f50524724e22

---

Thank you for the careful, detailed paper. Below I give a rigorous, point-by-point referee report in the format you requested. I treat the manuscript as a near–final working paper destined for a top general-interest journal and therefore am demanding on both methodological and presentation standards. My comments are structured exactly as you requested.

Summary (brief)
- Research question: Do state Medicaid postpartum coverage extensions (60 days → 12 months) increase Medicaid coverage among postpartum women?
- Data/strategy: ACS PUMS 2017–2019, 2021–2024; staggered DiD using Callaway & Sant’Anna (CS-DiD); triple-difference (postpartum vs non-postpartum low-income women); Rambachan–Roth (HonestDiD) sensitivity; wild-cluster bootstrap.
- Main result: No detectable increase in Medicaid coverage in survey data. CS-DiD ATT = −0.5 pp (SE = 0.7 pp). DDD CS-DiD = +1.0 pp (SE = 1.5 pp), not statistically significant. HonestDiD CI (M = 1): [−4.2, +3.7] pp.
- High-level take: Methodologically stronger than prior versions; still an important null result but with notable caveats (thin control group, measurement/attenuation, precision limits).

1. FORMAT CHECK
- Length: The LaTeX source is long. Judging from the main text, figures, and appendices, the manuscript well exceeds the 25-page minimum. My estimate: main text (excluding refs & appendix) ≈ 25–35 pages; full document including appendices ≈ 40–55 pages. That satisfies the page-length requirement for a top journal submission.
- References: Bibliography is substantial and includes most of the key econometrics and policy work relevant to DiD with staggered adoption (Callaway & Sant’Anna 2021; Goodman‑Bacon 2021; de Chaisemartin & D’Haultfœuille 2020; Sun & Abraham 2021; Rambachan & Roth 2023; Roth et al. 2023; Borusyak et al. 2024). It includes core policy literature on Medicaid and maternal health. Overall coverage is good, but see Section 4 (Literature) below for a few highly relevant empirical/methodological papers that are missing and should be cited (synthetic control literature for near‑universal adoption; papers on inference with few clusters; administrative-data work on postpartum Medicaid enrollment dynamics). I list specific missing citations and BibTeX entries in Section 4.
- Prose (structure): Major sections (Introduction, Institutional background, Conceptual framework, Data, Empirical strategy, Results, Robustness, Discussion, Conclusion) are written in paragraph form — acceptable for a top journal.
- Section depth: Intro, Institutional Background, Conceptual Framework, Data, Empirical Strategy, Results, Robustness, Discussion, Conclusion are all substantive and each contains multiple paragraphs. I judge section depth adequate.
- Figures: The LaTeX includes many figures and captions (raw trends, event studies, adoption map, DDD figure). I cannot see the rendered PDFs, but captions indicate the figures plot weighted rates, have clear labels, and note sample sizes. Before submission, confirm all figures: axes labeled with units (%), legends present, sample sizes shown or noted, fonts large enough for printing. (See specific figure suggestions below.)
- Tables: The tables referenced (summary statistics, main results, robustness, heterogeneity) appear to contain real numbers — not placeholders. Ensure table notes fully explain controls, weighting, clustering, and what “SE” means (clustered at the state level? wild bootstrap p-values?).

2. STATISTICAL METHODOLOGY (CRITICAL)
You correctly state “A paper CANNOT pass review without proper statistical inference.” I evaluate the manuscript against each required element.

a) Standard Errors
- PASS. All main coefficients reported have SEs. The manuscript reports standard errors (clustered at the state level) and also reports wild-cluster bootstrap p-values for some specifications. The HonestDiD intervals are reported. Make sure every regression table has SEs (or CIs) in parentheses and clearly documents clustering and any bootstrap p‑values.

b) Significance Testing
- PASS. You conduct hypothesis tests and report p-values (through WCB) and CIs in places. Make explicit in each table whether p-values are from asymptotic cluster-robust SEs or from wild-cluster bootstrap.

c) Confidence Intervals
- PARTIAL PASS. You report 95% CIs for event-study plots (shaded areas) and HonestDiD bounds. But main-table presentation should include 95% CIs (or both SEs and 95% CIs) for the principal ATT(s). Add CIs to key tables or a column with [lower, upper].

d) Sample sizes
- PASS. N is reported (Total postpartum N = 237,365; subsamples reported). But for every regression table you must report N and the number of clusters used for clustering (number of states) — particularly important when the effective number of clusters varies by specification (e.g., late-adopter analysis with 9 states). I recommend a column in each table: Observations = X; States (clusters) = S.

e) DiD with Staggered Adoption
- PASS (conditional). You correctly use Callaway & Sant’Anna (CS-DiD), which is the appropriate modern estimator to avoid TWFE bias with staggered timing. You also present TWFE as a biased benchmark and decompose via Goodman-Bacon. That meets the requirement. Two caveats:
  1. When aggregating CS-DiD ATT, clarify whether inference accounts for estimation of nuisance parameters and sampling weights (I assume the standard CS-DiD variance estimator is used). Show robustness using alternative aggregation weights.
  2. The near-universal adoption limiting the control pool (4 states) raises concerns about the reliability of state-level clustered inference; see below under Identification & Robustness.

f) RDD
- Not applicable. No RDD used. (So no McCrary needed.)

Overall statistical assessment: The paper satisfies the basic requirements for statistical inference and DiD methodology: coefficients have SEs, CIs and HonestDiD bounds are used, N and weights are reported, CS-DiD is used instead of naïve TWFE, placebo and DDD checks included. However, there remain important inferential threats that must be more explicitly addressed (few clusters, thin control group, ACS weighting & variance estimation, attenuation due to FER measurement). If those are not satisfactorily addressed, the paper is not publishable in a top journal. I therefore recommend addressing the items in Section 3 (Identification) and Section 6 (Constructive Suggestions) before publication.

If the methodology fails (i.e., if you did not include SEs, ignored staggered timing, or used TWFE without addressing biases), the paper would be unpublishable. That is not the case here — but see the caveats below.

3. IDENTIFICATION STRATEGY (credibility and threats)
- Parallel trends: You report pre-treatment event-study coefficients (e = −4, −3, −2) and state they are “small and statistically insignificant.” This is necessary but not sufficient. With only 3 pre-treatment years (2017–2019) and a thin control group, pre-trend tests have low power. The HonestDiD sensitivity analysis is a good attempt to quantify robustness to parallel-trends violations; still, be explicit about the limitations of the short pre-period and the reliability of the pre-trend anchor.
- Staggered timing and PHE: You correctly emphasize that the PHE continuous-enrollment provision strongly affected identification. Your post-PHE specification (restricting to 2017–2019 & 2023–2024) is a reasonable approach, and you sensibly report results both including and excluding 2023. However:
  - 2023 is a mixed year because unwinding started May 11, 2023. Because ACS lacks interview month, 2023 observations mix pre- and post-unwinding respondents; this contamination needs stronger discussion and sensitivity checks (e.g., re-run analysis with 2024-only post-period; report those estimates prominently).
  - The July 1 coding rule (treated if SPA effective on/before July 1) is arbitrary and dilutes exposure. Provide sensitivity to alternate cutoffs (April 1, Jan 1) and show how estimates change.
- Triple-difference (DDD): This is a sensible way to difference out secular shocks that affect all low-income women. The DDD is valuable and you present it. But the DDD relies on the assumption that secular trends between postpartum and non-postpartum low-income women are the same across treated and control states. Provide convincing placebo checks: show pre-trends for the DDD (differenced series) and test for parallel trends in that differenced series.
- Thin control group: This is the biggest identification concern. With only 4 control states (two never-adopters and two late adopters coded as not yet treated), (i) the standard DiD relies heavily on within-treated-group timing comparisons; (ii) inference clustered at the state-level has limited validity with few clusters; (iii) if any one control state is unusual, results can change. You do a leave-one-out sensitivity (dropping each control state) that reportedly yields identical point estimates (all −0.50 pp). That is reassuring but requires more detail: show full results for each leave-one-out run, with SEs and clustering details. Also consider synthetic-control-style approaches or cross-validation to supplement inference.
- Attenuation/measured exposure: You correctly frame ACS estimates as ITT with attenuation because FER lacks birth month and ACS is point-in-time. This is a fundamental measurement issue that weakens power — you acknowledge it. To strengthen identification, consider either (a) administrative Medicaid enrollment data (monthly enrollment spells) or (b) more targeted survey data that has interview or birth month (if available). At minimum, quantify the likely attenuation bias: simulate a simple model mapping true effect among fully exposed to expected ITT given uniform birth-month distribution and your July-1 coding rule.
- Inference with few clusters: You use wild cluster bootstrap (WCB) — good. But with small number of clusters (especially 9 or fewer in late-adopter analysis), WCB may still be unreliable. Cite and discuss the literature on inference with few clusters (Conley & Taber 2011; Carter, Schnepel, & Steigerwald? — more below) and consider permutation (“randomization”) inference where feasible (e.g., random assignment of treatment timing across states consistent with adoption patterns) or use the 'placebo re-randomization' approach to obtain empirical p-values.
- Heterogeneous treatment effects and aggregation: You use CS-DiD which is heterogeneity-robust; good. But present cohort-specific ATTs with SEs in the main text (not only in appendix) so readers can see if any particular cohort drives results. The Goodman-Bacon decomposition is included — show the component weights and the comparison types (treated vs untreated vs earlier/later) in a table.

Do conclusions follow from evidence?
- Largely yes. You are appropriately cautious: you call this a “well-identified null result in survey data” with several plausible explanations. That phrasing is appropriate given the limitations. However, be careful not to overstate identification — make clearer that “well-identified” is conditional on the assumptions (parallel trends, DDD assumption) and the limited control group.

Placebo tests and robustness checks
- You run many: high-income postpartum, non-postpartum low-income, employer-insurance placebo, leave-one-out, HonestDiD, WCB, late-adopter subset. This is commendable. For transparency, move a summary table of all major robustness results (including number of clusters per spec) into the main text.

4. LITERATURE (missing references and why they matter)
You cite most of the key econometric and health-policy literature. Still, the following specific papers would strengthen the methodological and empirical positioning of the paper. For each I give a brief justification and a BibTeX entry.

- Abadie, Diamond & Hainmueller (2010) — Synthetic Control. Rationale: when the control pool is thin (few untreated states), synthetic control is a natural complement to DiD and can help show whether the counterfactual is behaving unusually. Use it as a robustness check or to motivate why it wasn’t used.
```bibtex
@article{abadie2010synthetic,
  author = {Abadie, Alberto and Diamond, Alexis and Hainmueller, Jens},
  title = {Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California's Tobacco Control Program},
  journal = {Journal of the American Statistical Association},
  year = {2010},
  volume = {105},
  pages = {493--505}
}
```

- Conley & Taber (2011) — inference with few policy changes. Rationale: your setting has few untreated states and many treated states; Conley & Taber outline inference considerations with few treated/untreated policy changes.
```bibtex
@article{conley2011inference,
  author = {Conley, Timothy G. and Taber, Christopher R.},
  title = {Inference with `Difference in Differences' with a Small Number of Policy Changes},
  journal = {Review of Economics and Statistics},
  year = {2011},
  volume = {93},
  pages = {113--125}
}
```

- Athey & Imbens (2018) — design-based and synthetic control perspectives on DiD/event studies. Rationale: perspective on credible causal inference in comparative case studies, and guidance about interpretability when few units vary in treatment.
```bibtex
@article{athey2018design,
  author = {Athey, Susan and Imbens, Guido W.},
  title = {The State of Applied Econometrics: Causality and Policy Evaluation},
  journal = {Journal of Economic Perspectives},
  year = {2018},
  volume = {32},
  pages = {3--32}
}
```

- Rambachan & Roth (2022/2023) — you already cite the 2023 paper; ensure you include the correct reference and explain choices for \bar{M}, and provide code or exact implementation choices. (You do cite them; good.)

- Papers using administrative Medicaid enrollment data with monthly resolution for postpartum dynamics (examples):
  - Daw, Sommers, et al. (some older work) — you cite Daw et al. 2020 which is relevant. Also include papers that use state administrative data to study postpartum disenrollment and re-enrollment dynamics (for example, work by Wherry/Georgetown? If specific administrative studies exist on postpartum extension effects, cite them — some are in-state evaluations).
- If available, cite published administrative-data evaluations of postpartum extension impacts on actual enrollment spells (not just one working paper). You cite Krimmel et al. (working paper). If there are other state-analytic reports (MACPAC, state health depts.), include them.

- Papers on inference with few clusters & WCB properties (e.g., MacKinnon & Webb; Cameron, Gelbach & Miller 2008 you already cite — good). Consider adding:
```bibtex
@article{mackinnon2017wild,
  author = {MacKinnon, James G. and Webb, Matthew D.},
  title = {The Wild Bootstrap for Few Clusters},
  journal = {Econometrica},
  year = {2017},
  volume = {85},
  pages = {867--894}
}
```
(If you use WCB with few clusters, reference the literature that documents its properties.)

Why each is relevant: these references provide alternative inferential strategies (synthetic control, randomization/permutation inference, design-based cautions) and background for the statistical choices you make. They will strengthen reviewers’ confidence.

5. WRITING QUALITY (CRITICAL)
Overall the manuscript is well organized and readable for an empirical economics audience, but a top general-interest journal demands crisp, flowing prose as well as technical rigor. Below are targeted comments.

a) Prose vs bullets
- PASS. Major sections are written in paragraph form. The “Testable Predictions” list uses bullets/enumeration — that is acceptable.

b) Narrative Flow
- Strengths: Intro hooks on maternal mortality and the 60-day cliff; the PHE story provides a clear institutional complication that motivates the triple-difference and post-PHE analysis. The flow from motivation → data → method → robustness → interpretation is logical.
- Improvements:
  - The Introduction repeats some institutional background (e.g., PHE description) that could be condensed; move some material to Section 2 to tighten the intro.
  - Put a short “roadmap of contributions” paragraph in the Introduction with numbered bullets (e.g., 1. new data through 2024; 2. DDD design; 3. HonestDiD) but make it crisp (one paragraph).
  - In the Discussion, more clearly segregate empirical findings (what the data show) from speculative explanations (administrative substitution; measurement). The balance is currently reasonable but could be tightened.

c) Sentence Quality
- Overall good. A few long sentences (Intro paragraphs) could be broken for clarity. Use active voice where possible (many sentences are already active). Put the main quantitative results near the beginnings of paragraphs that discuss them.

d) Accessibility
- Good. Non-specialist economists can follow the argument. Still, add one short intuitive paragraph explaining why CS-DiD is preferred to TWFE (two lines) and why DDD helps with employer-insurance confounding, for readers less familiar with this literature.
- The “attenuation bias” point is crucial — provide a short back-of-the-envelope calculation in the main text (not only the appendix) showing how much attenuation to expect from FER lacking birth month. That will help non-technical policy readers understand why a 5–15 pp true effect could be measured close to zero in ACS.

e) Figures/Tables
- Make sure all figure titles are fully descriptive (e.g., “Weighted Medicaid Coverage Rate among Postpartum Women, ACS 2017–2024 (FER=1), by State Adoption Cohort”).
- Event-study plots: add horizontal zero line, label event-time ticks with calendar equivalents in a small sublabel (e.g., e=2 ≈ 2024 for 2022 cohort).
- Table notes: explicitly state sample, weighting, fixed effects, clustering, and whether wild-cluster bootstrap p-values are reported.

6. CONSTRUCTIVE SUGGESTIONS (to improve impact and address potential reviewer objections)
I think the paper is promising but requires additional analyses or clarifications to be competitive at AER/QJE/JPE/ReStud/AEJ:EP.

A. Strengthen inference given thin controls and few clusters
- Provide permutation-style inference: randomly assign adoption years to states (respecting the number of adopters and timing structure) to create empirical null distributions of the ATT and event-study coefficients. This helps assess whether observed ATTs are extreme relative to plausible randomization distributions.
- Implement synthetic control(s) for the earliest-adopting states and maybe for an aggregate treated group vs. synthetic control constructed from the 4 available untreated/late-adopter states. Present these as robustness checks, not replacements.
- Report cluster-robust SEs, WCB p-values, and permutation p-values side-by-side for key specifications.

B. Address measurement/attenuation bias explicitly
- Provide a quantitative attenuation calculation. For example, simulate the expected ITT effect under plausible distributions of birth months and the July‑1 coding rule. Show the implied scaling factor between the true full-exposure effect and the ITT estimate.
- If possible, obtain administrative enrollment data for a subset of states (even one state with a clear pre/post adoption and monthly enrollment) to directly measure enrollment spells and churning. If not yet possible, be explicit about plans or the feasibility of such work.

C. Sensitivity to treatment timing coding
- Re-code states as “treated” based on alternate cutoffs: state SPA effective on/before Jan 1; April 1 (the April 1 2022 SPA date you mention); July 1 (current). Show sensitivity of ATTs to these choices.
- Provide a version that exploits the exact effective date using a continuous exposure measure (e.g., fraction of the reference year treated) to reduce misclassification attenuation.

D. Emphasize DDD pre-trend checks
- Show the pre-treatment event-study for the differenced outcome (postpartum minus non-postpartum low-income) used in CS-DiD DDD. This demonstrates whether DDD parallel trends plausibly holds.

E. Heterogeneity and mechanisms
- Provide more granular heterogeneity: by Medicaid expansion status (you have this), by race/ethnicity (you mention it), and by age groups. If the overall effect is null but heterogeneous (positive for non-expansion states or Black women), that’s an important policy finding.
- Mechanism: present evidence on continuity vs. point-in-time coverage. For example, compute the fraction of postpartum women who report any Medicaid coverage vs. those who report employer or direct-purchase coverage; show how changes in churning/continuity could be masked by point-in-time ACS measures.

F. Clarify and expand the HonestDiD analysis
- Report HonestDiD results for several \bar{M} choices and explain why particular \bar{M} values are empirically plausible given your pre-period variation. Present these results in a small figure showing the CI as a function of \bar{M}.

G. Reframe the concluding policy message
- Make clear that the null in ACS does not mean the program is useless; highlight that additional administrative-data and utilization/health-outcome analyses are needed. Suggest specific follow-ups (state-level Medicaid enrollment analysis; hospital/postpartum care utilization; maternal mortality/morbidity outcomes).

7. OVERALL ASSESSMENT
Key strengths
- Careful use of modern DiD methodology (Callaway & Sant’Anna) and diagnostics (Goodman-Bacon decomposition).
- Thoughtful handling of the PHE complication (post-PHE specification, late-adopter focus).
- Triple-difference design is a strong and appropriate attempt to isolate postpartum-specific effects.
- Robustness battery includes HonestDiD sensitivity and wild-cluster bootstrap.
- Clear, policy-relevant research question with national importance.

Critical weaknesses
- Thin control group (only 4 untreated/untreated-in-sample states) is the dominant concern for identification and inference; it limits external validity and complicates clustering inference.
- Measurement attenuation due to ACS FER lacking birth month and point-in-time insurance measure undermines power and interpretability of ITT estimates. The paper acknowledges this but should quantify the magnitude.
- 2023 is a mixed year with ACS respondents both pre- and post-PHE unwinding — this is serious; it must be handled carefully (2024-only post-period is more convincing even if less powerful).
- Inference with few clusters and near‑universal adoption still leaves open the possibility that small but policy-relevant effects exist but are masked; the WCB approach may help but additional permutation/synthetic control checks are necessary.
- HonestDiD results show wide bounds; the paper’s title/abstract should be careful to frame the conclusion as: “No detectable effect in ACS survey data under stated assumptions” rather than a blanket policy claim.

Specific suggestions for improvement (succinct)
- Add explicit N’s and cluster counts to all result tables.
- Present the 2024-only post-period estimates prominently (even as a “primary robustness” if 2023 contamination is an issue).
- Quantify attenuation due to FER missing birth month (simple simulation/back-of-the-envelope).
- Implement permutation inference and at least one synthetic-control-style robustness check.
- Expand pre-trend DDD event-study diagnostics in main text.
- Add the missing references above and cite inference literature on few-cluster problems.
- Tighten prose in Intro/Discussion; place some institutional details in Section 2.

8. MINOR/TECHNICAL POINTS (page/section citations)
- Page 2 (Abstract, lines reporting SEs): For clarity, report 95% CIs in the abstract for the most important estimates or at least indicate significance level explicitly.
- Section 4 (Data): the mapping of adoption cohorts to event times (Table 1) is useful. In the text where you justify the July 1 cutoff, add a footnote showing sensitivity to alternative cutoffs.
- Section 5.5 (Inference): explicitly state the exact number of clusters used in each specification and how many treated vs control clusters are present in each specification (full sample, DDD, late-adopter).
- Section 6 (Results): when reporting the negative post-PHE ATT (−2.18 pp, SE 0.76), provide more discussion in the main text about the likely source (unwinding mechanics vs measurement). Your Discussion addresses this, but the main results section should also highlight that this counterintuitive sign is likely driven by structural dynamics and not an actual harm from the extension.
- Figures: ensure axis labels show “Percentage points” and that y-axis ranges are chosen so that small differences are visible but not misleading.

9. DECISION
The paper makes a careful and interesting contribution: a well-documented null result with careful methodology and a thoughtful discussion of measurement and institutional complications. However, the central identification threats — most importantly the very small control pool and the ACS measurement/attenuation problems — remain significant and require additional analyses or clarifications before acceptance at a top general-interest journal.

I therefore recommend a major revision that addresses the items above: add permutation/synthetic-control robustness, quantify attenuation, emphasize 2024-only post-period, more fully document cluster counts and inference choices, and insert a few key citations.

DECISION: MAJOR REVISION

If you resubmit, please include a short “response to reviewers” style appendix that (1) lists every new robustness check and where it is in the revised manuscript, (2) includes replication code snippets for the CS-DiD and HonestDiD implementations, and (3) provides explicit results from permutation/synthetic-control checks and the attenuation simulation. That will make it much easier for referees to judge whether the core identification concerns have been satisfactorily addressed.